Maiden Holdings, Ltd. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Maiden Holdings, Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $56.44M | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | $89.23M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $58.13M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $98.72M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $184.12M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $576.14M | Mar 15, 2021 |
| FY2018 | Dec 31, 2018 | $515.11M | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | $555.66M | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | $540.27M | Mar 15, 2019 |
| FY2018 | Mar 31, 2018 | $553.77M | Mar 15, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($200.97M) | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | ($38.57M) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | ($60.04M) | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $26.65M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $41.76M | Mar 14, 2022 |
| FY2019 | Dec 31, 2019 | ($131.90M) | Mar 18, 2020 |
| FY2018 | Dec 31, 2018 | ($269.24M) | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | ($308.84M) | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | ($5.91M) | Mar 15, 2019 |
| FY2018 | Mar 31, 2018 | $13.73M | Mar 15, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($67.45M) | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | ($59.78M) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | ($195.93M) | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | ($394.43M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | ($541.78M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($1.14B) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $182.29M | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $458.57M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $470.12M | Mar 15, 2019 |
| FY2017 | Dec 31, 2015 | $634.30M | Mar 1, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $341.0K | Mar 11, 2013 |
| FY2012 | Dec 31, 2011 | $1.54M | Mar 11, 2013 |
| FY2012 | Dec 31, 2010 | $2.88M | Mar 11, 2013 |
| FY2011 | Dec 31, 2009 | $1.75M | Mar 13, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.32B | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | $1.52B | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $1.85B | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $2.32B | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $2.95B | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $3.57B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $5.29B | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $6.64B | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $6.25B | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $5.70B | Mar 6, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.27B | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | $1.27B | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $1.56B | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $1.94B | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $2.42B | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $3.06B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $4.73B | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $5.41B | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $4.89B | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $4.35B | Mar 6, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $45.19M | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | $249.16M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $284.58M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $384.26M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $527.82M | Mar 14, 2022 |
| FY2019 | Dec 31, 2019 | $507.72M | Mar 18, 2020 |
| FY2019 | Dec 31, 2018 | $554.28M | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $1.23B | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $1.36B | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $1.35B | Mar 6, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | $57.19M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $57.19M | Mar 15, 2019 |
| FY2017 | Dec 31, 2015 | $58.94M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $58.31M | Mar 6, 2017 |
| FY2015 | Dec 31, 2013 | $58.31M | Mar 1, 2016 |
| FY2014 | Dec 31, 2012 | $58.31M | Mar 13, 2015 |
| FY2013 | Dec 31, 2011 | $58.31M | Mar 4, 2014 |
| FY2012 | Dec 31, 2010 | $58.43M | Mar 11, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($687.91M) | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | ($486.95M) | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | ($442.86M) | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | ($498.30M) | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | ($615.84M) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($695.79M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | ($563.89M) | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $35.47M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $285.66M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $316.18M | Mar 6, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $25.65M | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | $35.41M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $30.99M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $26.67M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $74.04M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $48.20M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $200.84M | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $54.47M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $41.28M | Mar 15, 2019 |
| FY2017 | Dec 31, 2015 | $89.64M | Mar 1, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $254.76M | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | $254.60M | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | $255.57M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $255.35M | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | $255.13M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $254.91M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $254.69M | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $254.48M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $351.41M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $349.93M | Mar 6, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (2) | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 14, 2022 |
| FY2018 | Dec 31, 2018 | (3) | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | (3) | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Mar 31, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | (1) | Mar 15, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (2) | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 10, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | 1 | Mar 15, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 14, 2022 |
| FY2018 | Dec 31, 2018 | (3) | Mar 15, 2019 |
| FY2018 | Sep 30, 2018 | (3) | Mar 15, 2019 |
| FY2018 | Jun 30, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Mar 31, 2018 | 0 | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | (1) | Mar 15, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 99.04M | Mar 10, 2025 |
| FY2024 | Dec 31, 2023 | 100.47M | Mar 10, 2025 |
| FY2024 | Dec 31, 2022 | 101.53M | Mar 10, 2025 |
| FY2023 | Dec 31, 2021 | 86.47M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | 84.80M | Mar 15, 2023 |
| FY2021 | Dec 31, 2019 | 83.15M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | 82.95M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | 82.97M | Mar 18, 2020 |
| FY2018 | Dec 31, 2016 | 86.27M | Mar 15, 2019 |
| FY2018 | Dec 31, 2015 | 73.72M | Mar 15, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Mar 18, 2020 |
| FY2019 | Dec 31, 2018 | $41.56M | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $51.63M | Mar 15, 2019 |
| FY2018 | Dec 31, 2016 | $43.13M | Mar 15, 2019 |
| FY2017 | Dec 31, 2015 | $38.20M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $32.08M | Mar 6, 2017 |
| FY2015 | Dec 31, 2013 | $19.61M | Mar 1, 2016 |
| FY2014 | Dec 31, 2012 | $29.63M | Mar 13, 2015 |
| FY2012 | Dec 31, 2011 | $20.92M | Mar 11, 2013 |
| FY2012 | Dec 31, 2010 | $18.39M | Mar 11, 2013 |